<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04530760</url>
  </required_header>
  <id_info>
    <org_study_id>2018_75</org_study_id>
    <secondary_id>2019-A02622-55</secondary_id>
    <nct_id>NCT04530760</nct_id>
  </id_info>
  <brief_title>Intraabdominal Hypertension and Occurrence of Microaspiration in Cirrhotics Under Mechanical Ventilation</brief_title>
  <acronym>ATOMIC</acronym>
  <official_title>Impact of Intraabdominal Hypertension on Microaspiration Incidence in Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to demonstrate the relationship between intra-abdominal hypertension (IAH) and&#xD;
      abundant microaspirations in mechanically ventilated cirrhotic.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intra-abdominal pressure monitoring will be performed using intra-vesical pressure every 8&#xD;
      hour in the first 2 days of mechanical ventilation.&#xD;
&#xD;
      Micro aspiration is defined by pepsin or amylase positivity in trachea suction. Two groups&#xD;
      will be compared : one with IAH , one without IAH.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>abundant microaspiration</measure>
    <time_frame>48 hours after inclusion</time_frame>
    <description>presence of pepsin or alpha amylase at significant level in at least 30% of tracheal aspirates</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>from ICU admission until day 28</time_frame>
    <description>number of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of ventilator associated pneumonia (VAP)</measure>
    <time_frame>from intubation until day 28 or extubation</time_frame>
    <description>percentage of patients with VAP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of mechanical ventilation</measure>
    <time_frame>from intubation until day 28 or extubation</time_frame>
    <description>number of days with mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of patients requiring renal replacement therapy</measure>
    <time_frame>from ICU admission until Day 28 or ICu discharge, whichever came first</time_frame>
    <description>percentage of patients with renal replacement treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of cirrhosis related complications</measure>
    <time_frame>from ICU admission until Day 28 or ICU discharge, whichever came first</time_frame>
    <description>percentage of patients with cirrhosis related complications</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">226</enrollment>
  <condition>Critical Illness</condition>
  <condition>Cirrhosis, Liver</condition>
  <arm_group>
    <arm_group_label>intraabdominal hypertension group</arm_group_label>
    <description>patients with intraabdominal hypertension defined as intravesical pressure more than 12 mmHg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>patients with no intraabdominal hypertension</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        cirrhotic patients receiving invasive mechanical ventilation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients&#xD;
&#xD;
          -  Cirrhosis&#xD;
&#xD;
          -  intubation and mechanical ventilation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  oliguric patients&#xD;
&#xD;
          -  impossibility to measure intravesical pressure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saad Nseir, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Saad Nseir, MD,PhD</last_name>
    <phone>0320444495</phone>
    <phone_ext>+33</phone_ext>
    <email>saadalla.nseir@chru-lille.fr</email>
  </overall_contact>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 27, 2020</study_first_submitted>
  <study_first_submitted_qc>August 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>March 25, 2021</last_update_submitted>
  <last_update_submitted_qc>March 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intra-Abdominal Hypertension</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

